Jazz Pharmaceuticals Ownership | Who Owns Jazz Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Jazz Pharmaceuticals Ownership Summary


Jazz Pharmaceuticals is owned by 57.86% institutional investors, 3.01% insiders, and 39.13% retail investors. Blackrock is the largest institutional shareholder, holding 9.83% of JAZZ shares. Pacer US Cash Cows 100 ETF is the top mutual fund, with 3.55% of its assets in Jazz Pharmaceuticals shares.

JAZZ Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockJazz Pharmaceuticals57.86%3.01%39.13%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%
IdeaCannabis Stocks List13.22%11.65%75.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock6.15M9.83%$655.94M
Vanguard group5.92M9.75%$1.01B
Blackrock funding, inc. /de5.59M9.17%$1.06B
Capital world investors2.67M4.38%$505.40M
Lsv asset management2.39M3.91%$451.23M
Fmr2.28M3.73%$430.23M
Franklin resources1.96M3.21%$370.34M
Dimensional fund advisors lp1.90M3.11%$358.26M
State street1.89M3.10%$357.62M
Ecor1 capital1.71M2.80%$322.61M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ecor1 capital1.71M13.69%$322.61M
Krensavage asset management167.82K12.41%$31.73M
Polaris capital management415.37K6.42%$78.52M
Saturn v capital management162.96K5.58%$30.81M
Goldentree asset management lp475.55K5.32%$89.76M
Superstring capital management lp40.89K5.31%$5.39M
Gmt capital581.00K5.01%$109.84M
Sofinnova investments598.33K4.30%$113.11M
Pfm health sciences, lp178.14K3.07%$33.68M
Avidity partners management lp234.50K2.84%$28.88M

Top Buyers

HolderShares% AssetsChange
Fmr2.28M0.02%1.47M
Citadel advisors1.26M0.04%948.32K
Bank of new york mellon1.68M0.06%517.51K
Aqr capital management1.34M0.11%461.19K
Vanguard fiduciary trust374.71K0.02%374.71K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---1.27M
Camber capital management lp---1.15M
Blackrock6.15M0.01%-924.16K
Dimensional fund advisors lp1.90M0.07%-728.09K
Rubric capital management lp---616.62K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust374.71K0.02%374.71K$70.84M
Assenagon asset management320.00K0.09%320.00K$60.50M
Centre asset management75.80K2.14%75.80K$9.34M
William blair investment management70.88K0.04%70.88K$13.40M
Tweedy, browne60.21K0.90%60.21K$11.38M

Sold Out

HolderChange
Psi advisors-1.00
Whittier trust co of nevada-1.00
Thurston, springer, miller, herd & titak-1.00
Center for financial planning-1.00
Private wealth asset management-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026398-32.88%35,288,267-42.71%570.56%210-32.26%112-42.27%
Dec 31, 2025394-23.79%42,392,171-30.10%690.71%191-15.49%134-31.98%
Sep 30, 2025488-2.59%58,731,791-0.37%951.03%208-15.10%1876.86%
Jun 30, 2025498-10.75%61,731,8556.44%1001.12%243-23.10%17512.18%
Mar 31, 20255528.02%58,706,955-0.60%961.04%31219.54%155-7.74%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Pacer US Cash Cows 100 ETF2.16M3.55%3.19K
Capital Group Fundamental Invtrs Comp2.10M3.41%-
American Funds Fundamental Invs A2.10M3.41%-
iShares Core S&P Mid-Cap ETF2.05M3.27%-1.04K
Vanguard US Total Market Shares ETF1.84M3.03%-44.10K
Vanguard Total Stock Mkt Idx Inv1.86M2.97%4.70K
FullerThaler Behavioral Sm-Cp Eq R61.60M2.60%50.02K
FullerThaler Beh Small-Cap Equity SMA1.60M2.60%20.00K
FullerThaler Behavioral Small-Cap Equity1.60M2.60%50.02K
Vanguard Small Cap Index1.35M2.15%-2.65K

Recent Insider Transactions


DateNameRoleActivityValue
May 28, 2026Patil Neena M EVP & Chief Legal OfficerSell$282.47K
May 28, 2026Pearce Samantha EVP, Chief Commercial OfficerSell$1.63M
May 22, 2026Winningham Rick E-Sell$662.14K
May 22, 2026McSharry Heather Ann-Sell$482.00K
May 01, 2026COZADD BRUCE C-Sell$1.22M

Insider Transactions Trends


DateBuySell
2026 Q2-8
2026 Q1-19
2025 Q4-18
2025 Q3-5
2025 Q245

JAZZ Ownership FAQ


Who Owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals shareholders are primarily institutional investors at 57.86%, followed by 3.01% insiders and 39.13% retail investors. The average institutional ownership in Jazz Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Jazz Pharmaceuticals exceeds.

Who owns the most shares of Jazz Pharmaceuticals?

Jazz Pharmaceuticals’s largest shareholders are Blackrock (6.15M shares, 9.83%), Vanguard group (5.92M shares, 9.75%), and Blackrock funding, inc. /de (5.59M shares, 9.17%). Together, they hold 28.75% of Jazz Pharmaceuticals’s total shares outstanding.

Does Blackrock own Jazz Pharmaceuticals?

Yes, BlackRock owns 9.83% of Jazz Pharmaceuticals, totaling 6.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 655.94M$. In the last quarter, BlackRock decreased its holdings by -924K shares, a -13.07% change.

Who is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ecor1 capital is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 13.69% of its assets in 1.71M Jazz Pharmaceuticals shares, valued at 322.61M$.

Who is the top mutual fund holder of Jazz Pharmaceuticals shares?

Pacer US Cash Cows 100 ETF is the top mutual fund holder of Jazz Pharmaceuticals shares, with 3.55% of its total shares outstanding invested in 2.16M Jazz Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools